Catalyst Wire Dossier Catalyst Wire Dossier

Durezol (difluprednate) ophthalmic emulsion

difluprednate · Sirion Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Durezol (difluprednate) ophthalmic emulsion, covering 2006-12-04 to 2006-12-04. Get the full timeline:

Most recent: Clinical Trial Update: Study of Difluprednate Ophthalmic Emulsion in Postoperative Inflammation [Phase 3]

See pricing